West of Scotland Lymphoma Group Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
1996
NCT00006232
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
1996

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 3 Trials (4)

doxorubicin (Doxil) (1 trial)

idarubicin (idamycin) (1 trial)

urea (1 trial)

vincristine (oncovin) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Multiple Myeloma (Phase 3)

Neoplasms, Plasma Cell (Phase 3)

Plasmacytoma (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 4